Ayala Pharmaceuticals
Clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for rare cancers.
30 employees · est. 2017 · Wilmington, United States
Immuneering Corporation
Helping Cancer Patients Live Longer and Feel Better
58 employees · est. 2008 · Cambridge, United States
Immuneering Corporation is the older company (2017 vs 2008); Immuneering Corporation is the larger of the two.
Side-by-Side Comparison
| Metric | Ayala Pharmaceuticals | Immuneering Corporation |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2008 older |
| Headquarters | ||
| Headquarters | Wilmington, United States | Cambridge, United States |
| Employees | ||
| Employees | 30 | 58 larger |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $72.00M | $112.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 4 |
| Services | ||
| Services | Not tracked yet | Development of oral, once-daily cancer therapeutics, Clinical trials for novel oncology drugs, Expansion of drug indications |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer patients, Healthcare providers, Oncologists, Medical researchers, Biotechnology investors |
| Taxonomy | ||
| Taxonomy | Clinical-stage Oncology, Small Molecule Therapeutics, Rare Cancers, Genetically Defined Patient Populations, Fast Track Designation, Gamma Secretase Inhibitors, Next-generation Sequencing, Precision Oncology, Targeted Therapy, Drug Development, Companion Diagnostics, Biomarkers, Rare Diseases | Biopharmaceutical Company, Translational Bioinformatics, Oncology Treatments, Neuroscience Programs, Drug Development Process, Patient Outcomes, Solid Tumors, Oncologic Signaling Pathways, MEK Inhibitor, RAS Mutant Tumors, MAPK Pathway, MTOR Pathway, Translational Planning, Immunotherapy, Precision Medicine |
| Website | ||
| Website | ayalapharma.com | immuneering.com |
About Ayala Pharmaceuticals
Ayala Pharmaceuticals is a clinical-stage oncology company that focuses on developing and commercializing small molecule therapeutics for rare cancers and aggressive tumors, as well as proprietary Lm-based antigen delivery products for more common cancers. Established in 2017 and headquartered in th...
About Immuneering Corporation
Immuneering Corporation, founded in 2008, is a pioneering biopharmaceutical company headquartered in the United States. Specializing in Biotechnology and Pharmaceuticals, Immuneering's slogan, “Better Medicines Through Signaling Dynamics,” reflects its commitment to enhancing patient outcomes in can...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Ayala Pharmaceuticals and Immuneering Corporation — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Ayala Pharmaceuticals and Immuneering Corporatio... — by email.
Frequently Asked Questions
Compare Ayala Pharmaceuticals with someone else
Start typing a company name or domain.